Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
63 studies found for:    Open Studies | Exclude Unknown | gastrointestinal diseases | NIDDK
Show Display Options
Rank Status Study
21 Recruiting Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
Condition: Eosinophilic Esophagitis
Intervention: Device: SECM Capsule
22 Recruiting Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Oral Viscous Budesonide;   Drug: Fluticasone MDI;   Drug: Placebo slurry;   Drug: Placebo inhaler
23 Recruiting Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Condition: Irritable Bowel Syndrome (IBS)
Interventions: Other: Fructan;   Other: Maltodextrin
24 Recruiting Neuromodulation Therapy for Fecal Incontinence
Condition: Fecal Incontinence
Intervention: Procedure: Repetitive magnetic stimulation
25 Recruiting DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
Condition: Diverticulitis
26 Recruiting Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
Conditions: Liver Disease;   Fatty Liver
27 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
28 Recruiting Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Condition: Chronic Hepatitis C
Interventions: Drug: Sofosbuvir;   Drug: GS-5816
29 Recruiting Natural History of Noncirrhotic Portal Hypertension
Conditions: Cystic Fibrosis;   Immunologic Deficiency Syndrome;   Turner Syndrome;   Congenital Hepatic Fibrosis;   Idiopathic Non-Cirrhotic Portal Hypertension
30 Recruiting Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
Condition: Cirrhosis
31 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
32 Recruiting Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
Condition: Fatty Liver
33 Recruiting Seroprevalence of Hepatitis E in People With an Organ Transplant
Condition: Hepatitis E
34 Recruiting Evaluation of Sickle Cell Liver Disease
Condition: Sickle Cell Disease
35 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Drug: Vitamin E 200 IU/d;   Drug: Vitamin E 400 IU/d;   Drug: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
36 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
37 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
38 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & Emtricitabine;   Drug: Tenofovir
39 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
40 Recruiting Diagnosing and Treating Low Blood Sugar Levels
Conditions: Hypoglycemia;   Insulinoma

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years